Country
Contract Development & Manufacturing Organizations in the Netherlands
A biologics and advanced-therapy hub at the heart of EU logistics. Compare EU-GMP Dutch CDMOs across biologics, cell & gene therapy, and drug product — by capability and site.
43 companies listed
Manufacturing sites in Netherlands
The Dutch CDMO landscape
The Netherlands trades breadth for specialisation. Its contract-manufacturing base is smaller than Germany's or France's but disproportionately weighted toward the modalities that are hardest to source: biologics, viral vectors and cell & gene therapy, vaccines, and antibody-drug conjugates. For an advanced-therapy programme, the Dutch shortlist is often longer than the German one.
The competent authority for medicines is the CBG-MEB (College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board), working alongside the national health and youth care inspectorate on GMP oversight; certificates issued in the Netherlands are recognised across the EU. The EMA's post-Brexit relocation to Amsterdam put the European regulator on Dutch soil, which matters less for inspections than people assume but genuinely helps for scientific advice and regulatory staffing.
Logistics is the underrated argument. Schiphol and the Port of Rotterdam give Dutch sites some of the best cold-chain and distribution infrastructure in Europe, and a large share of pharmaceutical product entering the EU already moves through them. For a sponsor building an EU supply chain rather than just an EU manufacturing step, that shortens the distance between release and market.
Where Dutch manufacturing actually happens
Leiden Bio Science Park is the country's primary life-science cluster and the heart of its biologics and vaccine capability, combining manufacturing with a dense concentration of biotech, academic, and analytical organisations on one campus.
Oss, in the south, hosts Pivot Park — a life-science campus built on a long-established pharmaceutical manufacturing and research site — which has become a base for development-scale and specialist contract operations.
Nijmegen and the wider Gelderland region carry notable ADC and conjugation expertise, while Groningen and Amsterdam add API, drug-product, and clinical-supply capacity. The country is compact enough that these clusters function as one labour market — a practical advantage when a programme needs several specialist partners at once.
Companies (43)
Aragen Life Sciences Ltd.
Netherlands
Arcadis
Netherlands
Ardena
Netherlands
Arxada (CDMO)
Netherlands
Aspen API
Netherlands
Avivia BV
Netherlands
Basic Pharma
Netherlands
Batavia Biosciences
Netherlands
BioConnection
Netherlands
B
Biosynth (previously known as Pepscan Holding NV)
Netherlands
CARBOGEN AMCIS
Netherlands
C
Cergentis
Netherlands
Chemleg Europe B.V.
Netherlands
Cold Chain Technologies (CCT)
Netherlands
Delpharm
Netherlands
Dishman Carbogen Amcis Ltd
Netherlands
Disphar International BV
Netherlands
Eurofins Biopharma Services (CDMO)
Netherlands
European Medical Contract Manufacturing (EMCM)
Netherlands
Fisher BioServices (Thermo Fisher)
Netherlands
HALIX
Netherlands
InnoGenerics
Netherlands
InnoSyn BV
Netherlands
Intravacc
Netherlands
Katwijk Chemie BV
Netherlands
KLK OLEO Life Science
Netherlands
KPMG
Netherlands
Lonza
Netherlands
Ncardia
Netherlands
NewAmsterdam Pharma
Netherlands
Ofichem Group
Netherlands
Pharmathen
Netherlands
RiboPro B.V.
Netherlands
Sanquin Blood Supply Foundation
Netherlands
Serum Institute of India (SII)
Netherlands
Sharp Sterile Manufacturing
Netherlands
Symeres
Netherlands
Tiofarma
Netherlands
TNO – Efficient Drug Development (TNO Healthy)
Netherlands
VanBerkel Consultancy
Netherlands
VLCI - Van Loon Chemical Innovation
Netherlands
Wacker Biotech
Netherlands
ZoBio
Netherlands
How this list is built: companies appear here when they have a manufacturing site in Netherlands in our facilities dataset and pass the marketplace eligibility gate (pharmaceutical contract manufacturers only — CROs, equipment suppliers, and other non-manufacturers are excluded). Read the full methodology for the eligibility gates and how our ranked lists are computed.
Frequently Asked Questions
How many CDMOs are in the Netherlands?+
CDMO Hub lists a focused Dutch roster — the live count and ranked list above are derived from verified manufacturing sites in the country.
What are Dutch CDMOs strongest in?+
Biologics, viral vectors and cell & gene therapy, vaccines, and antibody-drug conjugates — the harder-to-source modalities. Leiden Bio Science Park anchors the biologics and vaccine base, while the Nijmegen region carries notable conjugation expertise.
Who regulates pharmaceutical manufacturing in the Netherlands?+
The CBG-MEB (College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board) is the national medicines authority, with GMP oversight exercised alongside the national health inspectorate. Dutch EU GMP certificates are recognised across the Union, and the EMA itself is headquartered in Amsterdam following its post-Brexit relocation.
Why does Dutch logistics matter for drug manufacturing?+
Schiphol and the Port of Rotterdam give Dutch sites exceptional cold-chain and distribution infrastructure, and a large share of pharmaceutical product entering the EU already moves through them. For sponsors building an EU supply chain rather than a single manufacturing step, that shortens the path from batch release to market.
Find the right CDMO in Netherlands
Our AI Matchmaker analyzes your project requirements and matches you with qualified Netherlands manufacturing partners. Free for buyers.